Margarita Chavez

Margarita is Managing Director at AbbVie Ventures. Margarita has led investments in more than a dozen biotech companies in the United States and Europe. She is responsible for AbbVie Ventures’ investments in Alector, Morphic Therapeutics, CARISMA Therapeutics, Jnana Therapeutics, and more. Margarita brings more than 20 years of experience with over a decade of biotech licensing, IPOs, and acquisitions. As a Director with Abbott’s Global Pharmaceutical Licensing & Acquisitions, she was involved in the in-licensing of Elagolix, the acquisition of Solvay and Immuven, and the acquisition of the Lupron franchise. Before joining Abbott, Margarita practiced as a corporate and securities lawyer in Silicon Valley with Brobeck, Phleger & Harrison. Margarita received her BS from Santa Clara University and her JD from Santa Clara University School of Law.